Literature DB >> 19864593

CXCR2 is required for neutrophilic airway inflammation and hyperresponsiveness in a mouse model of human rhinovirus infection.

Deepti R Nagarkar1, Qiong Wang, Jee Shim, Ying Zhao, Wan C Tsai, Nicholas W Lukacs, Uma Sajjan, Marc B Hershenson.   

Abstract

Human rhinovirus (RV) infection is responsible for the majority of virus-induced asthma exacerbations. Using a mouse model of human RV infection, we sought to determine the requirement of CXCR2, the receptor for ELR-positive CXC chemokines, for RV-induced airway neutrophilia and hyperresponsiveness. Wild-type and CXCR2(-/-) mice were inoculated intranasally with RV1B or sham HeLa cell supernatant. Following RV1B infection, CXCR2(-/-) mice showed reduced airway and lung neutrophils and cholinergic responsiveness compared with wild-type mice. Similar results were obtained in mice treated with neutralizing Ab to Ly6G, a neutrophil-depleting Ab. Lungs from RV-infected, CXCR2(-/-) mice showed significantly reduced production of TNF-alpha, MIP-2/CXCL2, and KC/CXCL1 and lower expression of MUC5B compared with RV-treated wild-type mice. The requirement of TNF-alpha for RV1B-induced airway responses was tested using TNFR1(-/-) mice. TNFR1(-/-) animals displayed reduced airway responsiveness to RV1B, even when exogenous MIP-2 was added to the airways. We conclude that CXCR2 is required for RV-induced neutrophilic airway inflammation and that neutrophil TNF-alpha release is required for airway hyperresponsiveness.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19864593      PMCID: PMC2952174          DOI: 10.4049/jimmunol.0900298

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

Review 1.  The neutrophil as a cellular source of chemokines.

Authors:  P Scapini; J A Lapinet-Vera; S Gasperini; F Calzetti; F Bazzoni; M A Cassatella
Journal:  Immunol Rev       Date:  2000-10       Impact factor: 12.988

2.  Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-kappaB-mediated transcription.

Authors:  A Papi; S L Johnston
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

3.  Expression and functional analysis of chemokine receptors in human peripheral blood leukocyte populations.

Authors:  L Patel; S J Charlton; J K Chambers; C H Macphee
Journal:  Cytokine       Date:  2001-04-07       Impact factor: 3.861

4.  Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection.

Authors:  J E Gern; R Vrtis; K A Grindle; C Swenson; W W Busse
Journal:  Am J Respir Crit Care Med       Date:  2000-12       Impact factor: 21.405

5.  Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes.

Authors:  R Bonecchi; F Facchetti; S Dusi; W Luini; D Lissandrini; M Simmelink; M Locati; S Bernasconi; P Allavena; E Brandt; F Rossi; A Mantovani; S Sozzani
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

6.  Tumor necrosis factor-alpha-induced activation of RhoA in airway smooth muscle cells: role in the Ca2+ sensitization of myosin light chain20 phosphorylation.

Authors:  Irene Hunter; Hannah J Cobban; Peter Vandenabeele; David J MacEwan; Graeme F Nixon
Journal:  Mol Pharmacol       Date:  2003-03       Impact factor: 4.436

7.  Interleukin-1beta and interleukin-1ra levels in nasal lavages during experimental rhinovirus infection in asthmatic and non-asthmatic subjects.

Authors:  J de Kluijver; K Grünberg; D Pons; E P A de Klerk; C R Dick; P J Sterk; P S Hiemstra
Journal:  Clin Exp Allergy       Date:  2003-10       Impact factor: 5.018

8.  Mouse respiratory epithelial cells support efficient replication of human rhinovirus.

Authors:  Tobias J Tuthill; Nikolaos G Papadopoulos; Patrick Jourdan; Lisa J Challinor; Nigel A Sharp; Chris Plumpton; Ketaki Shah; Suzanne Barnard; Laura Dash; Jerome Burnet; Richard A Killington; David J Rowlands; Neil J Clarke; Edward D Blair; Sebastian L Johnston
Journal:  J Gen Virol       Date:  2003-10       Impact factor: 3.891

9.  Rhinovirus induction of the CXC chemokine epithelial-neutrophil activating peptide-78 in bronchial epithelium.

Authors:  Howard Donninger; Richard Glashoff; Hans-Michael Haitchi; James A Syce; Reena Ghildyal; Estrelita van Rensburg; Philip G Bardin
Journal:  J Infect Dis       Date:  2003-06-01       Impact factor: 5.226

10.  Rhinovirus infection in nonasthmatic subjects: effects on intrapulmonary airways.

Authors:  J de Kluijver; K Grünberg; J K Sont; M Hoogeveen; W A A M van Schadewijk; E P A de Klerk; C R Dick; J H J M van Krieken; P J Sterk
Journal:  Eur Respir J       Date:  2002-08       Impact factor: 16.671

View more
  52 in total

1.  Elastase/LPS-exposed mice exhibit impaired innate immune responses to bacterial challenge: role of scavenger receptor A.

Authors:  Shyamala Ganesan; Andrea N Faris; Adam T Comstock; Joanne Sonstein; Jeffrey L Curtis; Uma S Sajjan
Journal:  Am J Pathol       Date:  2011-11-08       Impact factor: 4.307

2.  CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis.

Authors:  Gong Yang; Daniel G Rosen; Guangzhi Liu; Fan Yang; Xiaoqing Guo; Xue Xiao; Fengxia Xue; Imelda Mercado-Uribe; Jiaoti Huang; Sue-Hwa Lin; Gordon B Mills; Jinsong Liu
Journal:  Clin Cancer Res       Date:  2010-05-26       Impact factor: 12.531

3.  High expression of CXCR2 is associated with tumorigenesis, progression, and prognosis of laryngeal squamous cell carcinoma.

Authors:  Liang Han; Bin Jiang; Hao Wu; Xudong Wang; Xiaojun Tang; Jianfei Huang; Jin Zhu
Journal:  Med Oncol       Date:  2012-01-25       Impact factor: 3.064

4.  MicroRNA-26a/-26b-COX-2-MIP-2 Loop Regulates Allergic Inflammation and Allergic Inflammation-promoted Enhanced Tumorigenic and Metastatic Potential of Cancer Cells.

Authors:  Yoojung Kwon; Youngmi Kim; Sangkyung Eom; Misun Kim; Deokbum Park; Hyuna Kim; Kyeonga Noh; Hansoo Lee; Yun Sil Lee; Jongseon Choe; Young Myeong Kim; Dooil Jeoung
Journal:  J Biol Chem       Date:  2015-04-23       Impact factor: 5.157

Review 5.  The airway epithelium: soldier in the fight against respiratory viruses.

Authors:  Marjolaine Vareille; Elisabeth Kieninger; Michael R Edwards; Nicolas Regamey
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

6.  Enterovirus D68 infection induces IL-17-dependent neutrophilic airway inflammation and hyperresponsiveness.

Authors:  Charu Rajput; Mingyuan Han; J Kelley Bentley; Jing Lei; Tomoko Ishikawa; Qian Wu; Joanna L Hinde; Amy P Callear; Terri L Stillwell; William T Jackson; Emily T Martin; Marc B Hershenson
Journal:  JCI Insight       Date:  2018-08-23

7.  Rhinovirus Infection of ORMDL3 Transgenic Mice Is Associated with Reduced Rhinovirus Viral Load and Airway Inflammation.

Authors:  Dae Jin Song; Marina Miller; Andrew Beppu; Peter Rosenthal; Sudipta Das; Maya Karta; Christine Vuong; Amit Kumar Mehta; Michael Croft; David H Broide
Journal:  J Immunol       Date:  2017-08-21       Impact factor: 5.422

8.  Neonatal hyperoxia contributes additively to cigarette smoke-induced chronic obstructive pulmonary disease changes in adult mice.

Authors:  Sharon A McGrath-Morrow; Thomas Lauer; J Michael Collaco; Min Yee; Michael O'Reilly; Wayne Mitzner; Enid Neptune; Robert Wise; Shyam Biswal
Journal:  Am J Respir Cell Mol Biol       Date:  2011-01-14       Impact factor: 6.914

9.  Bacterial Dose-Dependent Role of G Protein-Coupled Receptor Kinase 5 in Escherichia coli-Induced Pneumonia.

Authors:  Nandakumar Packiriswamy; Michael Steury; Ian C McCabe; Scott D Fitzgerald; Narayanan Parameswaran
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

10.  TLR2 Activation Limits Rhinovirus-Stimulated CXCL-10 by Attenuating IRAK-1-Dependent IL-33 Receptor Signaling in Human Bronchial Epithelial Cells.

Authors:  Shyamala Ganesan; Duc Pham; Yaxun Jing; Mohammad Farazuddin; Magdalena H Hudy; Benjamin Unger; Adam T Comstock; David Proud; Adam S Lauring; Uma S Sajjan
Journal:  J Immunol       Date:  2016-08-08       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.